Cardlytics (CDLX) Competitors

$0.63 -0.02 (-2.32%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$0.63 -0.01 (-0.79%)

As of 05/15/2026 04:46 PM Eastern

CDLX vs. DKI, ROC, HCAT, ARBE, and CANG

Should you buy Cardlytics stock or one of its competitors? MarketBeat compares Cardlytics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardlytics include DarkIris (DKI), Rank One Computing (ROC), Health Catalyst (HCAT), Arbe Robotics (ARBE), and Cango (CANG). These companies are all part of the "computer software" industry.

How does Cardlytics compare to DarkIris?

DarkIris (NASDAQ:DKI) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

DarkIris has a net margin of 0.00% compared to Cardlytics' net margin of -46.03%. DarkIris' return on equity of 0.00% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarkIris	N/A	N/A	N/A
Cardlytics	-46.03%	-956.56%	-34.57%

Cardlytics has a consensus target price of $1.00, indicating a potential upside of 58.23%. Given Cardlytics' stronger consensus rating and higher possible upside, analysts plainly believe Cardlytics is more favorable than DarkIris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarkIris	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

In the previous week, Cardlytics had 1 more articles in the media than DarkIris. MarketBeat recorded 3 mentions for Cardlytics and 2 mentions for DarkIris. DarkIris' average media sentiment score of 0.94 beat Cardlytics' score of 0.21 indicating that DarkIris is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarkIris	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

68.1% of Cardlytics shares are owned by institutional investors. 5.9% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

DarkIris has higher earnings, but lower revenue than Cardlytics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarkIris	N/A	N/A	N/A	N/A	N/A
Cardlytics	$233.27M	0.16	-$103.49M	-$1.77	N/A

Summary

Cardlytics beats DarkIris on 6 of the 10 factors compared between the two stocks.

How does Cardlytics compare to Rank One Computing?

Rank One Computing (NASDAQ:ROC) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Rank One Computing has a net margin of 0.00% compared to Cardlytics' net margin of -46.03%. Rank One Computing's return on equity of 0.00% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rank One Computing	N/A	N/A	N/A
Cardlytics	-46.03%	-956.56%	-34.57%

Rank One Computing currently has a consensus target price of $9.00, indicating a potential upside of 55.98%. Cardlytics has a consensus target price of $1.00, indicating a potential upside of 58.23%. Given Cardlytics' higher probable upside, analysts clearly believe Cardlytics is more favorable than Rank One Computing.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rank One Computing	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

In the previous week, Rank One Computing had 2 more articles in the media than Cardlytics. MarketBeat recorded 5 mentions for Rank One Computing and 3 mentions for Cardlytics. Rank One Computing's average media sentiment score of 0.73 beat Cardlytics' score of 0.21 indicating that Rank One Computing is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rank One Computing	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rank One Computing has higher earnings, but lower revenue than Cardlytics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rank One Computing	$16.98M	6.48	N/A	N/A	N/A
Cardlytics	$233.27M	0.16	-$103.49M	-$1.77	N/A

68.1% of Cardlytics shares are owned by institutional investors. 22.2% of Rank One Computing shares are owned by insiders. Comparatively, 5.9% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Rank One Computing beats Cardlytics on 9 of the 12 factors compared between the two stocks.

How does Cardlytics compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Health Catalyst has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market. Comparatively, Cardlytics has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Cardlytics has a net margin of -46.03% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Cardlytics	-46.03%	-956.56%	-34.57%

Health Catalyst currently has a consensus target price of $2.77, indicating a potential upside of 133.00%. Cardlytics has a consensus target price of $1.00, indicating a potential upside of 58.23%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts clearly believe Health Catalyst is more favorable than Cardlytics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

In the previous week, Health Catalyst had 16 more articles in the media than Cardlytics. MarketBeat recorded 19 mentions for Health Catalyst and 3 mentions for Cardlytics. Health Catalyst's average media sentiment score of 0.36 beat Cardlytics' score of 0.21 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cardlytics has lower revenue, but higher earnings than Health Catalyst. Cardlytics is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.28	-$177.97M	-$3.72	N/A
Cardlytics	$233.27M	0.16	-$103.49M	-$1.77	N/A

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 68.1% of Cardlytics shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by insiders. Comparatively, 5.9% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Health Catalyst beats Cardlytics on 12 of the 16 factors compared between the two stocks.

How does Cardlytics compare to Arbe Robotics?

Arbe Robotics (NASDAQ:ARBE) and Cardlytics (NASDAQ:CDLX) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Arbe Robotics has higher earnings, but lower revenue than Cardlytics. Arbe Robotics is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arbe Robotics	$1.03M	125.52	-$46.42M	-$0.41	N/A
Cardlytics	$233.27M	0.16	-$103.49M	-$1.77	N/A

Cardlytics has a net margin of -46.03% compared to Arbe Robotics' net margin of -4,402.73%. Arbe Robotics' return on equity of -82.00% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arbe Robotics	-4,402.73%	-82.00%	-57.89%
Cardlytics	-46.03%	-956.56%	-34.57%

In the previous week, Arbe Robotics and Arbe Robotics both had 3 articles in the media. Arbe Robotics' average media sentiment score of 1.07 beat Cardlytics' score of 0.21 indicating that Arbe Robotics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arbe Robotics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

33.4% of Arbe Robotics shares are owned by institutional investors. Comparatively, 68.1% of Cardlytics shares are owned by institutional investors. 53.5% of Arbe Robotics shares are owned by insiders. Comparatively, 5.9% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Arbe Robotics has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, Cardlytics has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Arbe Robotics currently has a consensus target price of $2.25, indicating a potential upside of 114.29%. Cardlytics has a consensus target price of $1.00, indicating a potential upside of 58.23%. Given Arbe Robotics' stronger consensus rating and higher probable upside, analysts clearly believe Arbe Robotics is more favorable than Cardlytics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arbe Robotics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

Summary

Arbe Robotics beats Cardlytics on 10 of the 15 factors compared between the two stocks.

How does Cardlytics compare to Cango?

Cardlytics (NASDAQ:CDLX) and Cango (NYSE:CANG) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Cardlytics has a net margin of -46.03% compared to Cango's net margin of -83.92%. Cango's return on equity of -49.13% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Cango	-83.92%	-49.13%	-24.42%

In the previous week, Cango had 8 more articles in the media than Cardlytics. MarketBeat recorded 11 mentions for Cango and 3 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.21 beat Cango's score of -0.25 indicating that Cardlytics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cango	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cardlytics presently has a consensus target price of $1.00, suggesting a potential upside of 58.23%. Cango has a consensus target price of $3.00, suggesting a potential upside of 475.82%. Given Cango's stronger consensus rating and higher possible upside, analysts plainly believe Cango is more favorable than Cardlytics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Cardlytics has higher earnings, but lower revenue than Cango. Cardlytics is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.16	-$103.49M	-$1.77	N/A
Cango	$688.08M	0.13	-$621.95M	-$2.97	N/A

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 4.2% of Cango shares are owned by institutional investors. 5.9% of Cardlytics shares are owned by insiders. Comparatively, 29.1% of Cango shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cardlytics has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Cango has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market.

Summary

Cango beats Cardlytics on 11 of the 17 factors compared between the two stocks.

Get Cardlytics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDLX vs. The Competition

Export

Metric	Cardlytics	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$37.27M	$3.78B	$6.33B	$12.47B
Dividend Yield	N/A	2.16%	3.18%	5.28%
P/E Ratio	-0.36	51.82	30.63	25.23
Price / Sales	0.16	46.77	436.42	83.05
Price / Cash	N/A	40.21	23.29	56.04
Price / Book	-9.03	5.36	6.72	6.91
Net Income	-$103.49M	$32.12M	$200.18M	$334.11M
7 Day Performance	-1.25%	8.23%	1.87%	0.01%
1 Month Performance	-33.64%	-3.82%	-2.99%	1.17%
1 Year Performance	-69.32%	27.29%	31.36%	30.68%

Cardlytics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDLX Cardlytics	1.7995 of 5 stars	$0.63 -2.3%	$1.00 +58.2%	-68.2%	$37.27M	$233.27M	N/A	500	Gap Up
DKI DarkIris	1.1146 of 5 stars	$5.46 -2.8%	N/A	N/A	$118.10M	N/A	N/A	23	Gap Down
ROC Rank One Computing	4.1213 of 5 stars	$6.03 +1.2%	$9.00 +49.2%	N/A	$113.24M	$16.98M	N/A	77	News Coverage Earnings Report
HCAT Health Catalyst	2.4225 of 5 stars	$1.49 +7.6%	$2.77 +86.7%	-71.0%	$110.02M	$311.14M	N/A	1,200	Earnings Report Analyst Forecast
ARBE Arbe Robotics	2.3525 of 5 stars	$0.86 -4.4%	$2.25 +162.5%	-29.1%	$104.87M	$1.03M	N/A	120	Positive News Upcoming Earnings Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDLX) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardlytics (CDLX) Competitors

CDLX vs. DKI, ROC, HCAT, ARBE, and CANG

How does Cardlytics compare to DarkIris?

Summary

How does Cardlytics compare to Rank One Computing?

Summary

How does Cardlytics compare to Health Catalyst?

Summary

How does Cardlytics compare to Arbe Robotics?

Summary

How does Cardlytics compare to Cango?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cardlytics (CDLX) Competitors

CDLX vs. DKI, ROC, HCAT, ARBE, and CANG

How does Cardlytics compare to DarkIris?

Is DKI or CDLX more profitable?

Do analysts prefer DKI or CDLX?

Does the media refer more to DKI or CDLX?

Do insiders & institutionals believe in DKI or CDLX?

Which has stronger earnings & valuation, DKI or CDLX?

Summary

How does Cardlytics compare to Rank One Computing?

Is ROC or CDLX more profitable?

Do analysts rate ROC or CDLX?

Does the media favor ROC or CDLX?

Which has higher earnings and valuation, ROC or CDLX?

Do insiders & institutionals believe in ROC or CDLX?

Summary

How does Cardlytics compare to Health Catalyst?

Which has more risk & volatility, HCAT or CDLX?

Is HCAT or CDLX more profitable?

Do analysts rate HCAT or CDLX?

Does the media refer more to HCAT or CDLX?

Which has higher earnings and valuation, HCAT or CDLX?

Do insiders & institutionals believe in HCAT or CDLX?

Summary

How does Cardlytics compare to Arbe Robotics?

Which has higher earnings and valuation, ARBE or CDLX?

Is ARBE or CDLX more profitable?

Does the media refer more to ARBE or CDLX?

Do insiders & institutionals believe in ARBE or CDLX?

Which has more risk & volatility, ARBE or CDLX?

Do analysts rate ARBE or CDLX?

Summary

How does Cardlytics compare to Cango?

Is CDLX or CANG more profitable?

Does the media favor CDLX or CANG?

Do analysts rate CDLX or CANG?

Which has preferable valuation and earnings, CDLX or CANG?

Do institutionals & insiders hold more shares of CDLX or CANG?

Which has more volatility and risk, CDLX or CANG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools